DE122005000012I1 - N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutamins{urederivate. - Google Patents
N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutamins{urederivate.Info
- Publication number
- DE122005000012I1 DE122005000012I1 DE200512000012 DE122005000012C DE122005000012I1 DE 122005000012 I1 DE122005000012 I1 DE 122005000012I1 DE 200512000012 DE200512000012 DE 200512000012 DE 122005000012 C DE122005000012 C DE 122005000012C DE 122005000012 I1 DE122005000012 I1 DE 122005000012I1
- Authority
- DE
- Germany
- Prior art keywords
- ylacyl
- glutamins
- pyrrolo
- pyrimidin
- acid derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002253 acid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44874289A | 1989-12-11 | 1989-12-11 | |
| US47965590A | 1990-02-08 | 1990-02-08 | |
| US07/528,155 US5028608A (en) | 1989-12-11 | 1990-05-24 | N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives |
| US07/528,805 US4996206A (en) | 1989-12-11 | 1990-05-24 | N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE122005000012I1 true DE122005000012I1 (de) | 2005-06-23 |
| DE122005000012I2 DE122005000012I2 (de) | 2006-02-09 |
Family
ID=27503964
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69025723T Expired - Lifetime DE69025723T2 (de) | 1989-12-11 | 1990-12-10 | N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutaminsäurederivate |
| DE200512000012 Active DE122005000012I2 (de) | 1989-12-11 | 1990-12-10 | N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl-Glutamins{urederivate |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69025723T Expired - Lifetime DE69025723T2 (de) | 1989-12-11 | 1990-12-10 | N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutaminsäurederivate |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0432677B1 (de) |
| JP (1) | JP3016876B2 (de) |
| CN (1) | CN1030608C (de) |
| AR (1) | AR245129A1 (de) |
| AT (1) | ATE135007T1 (de) |
| AU (1) | AU640182B2 (de) |
| CA (1) | CA2031890C (de) |
| CY (1) | CY2076B1 (de) |
| DE (2) | DE69025723T2 (de) |
| DK (1) | DK0432677T3 (de) |
| ES (1) | ES2084639T4 (de) |
| GR (1) | GR3019784T3 (de) |
| HU (1) | HU218483B (de) |
| IE (1) | IE904445A1 (de) |
| IL (1) | IL96531A (de) |
| LU (1) | LU91147I2 (de) |
| NL (1) | NL300181I2 (de) |
| NZ (1) | NZ236385A (de) |
| PT (1) | PT96140B (de) |
| RU (1) | RU2057131C9 (de) |
| SG (1) | SG48098A1 (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254687A (en) | 1991-12-04 | 1993-10-19 | The Trustees Of Princeton University | Process for the preparation of pyrrolo[2,3-d]pyrimidines |
| US5235053A (en) * | 1992-06-22 | 1993-08-10 | Eli Lilly And Company | Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates |
| CA2477088A1 (en) | 2002-02-22 | 2003-10-02 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| CN100344615C (zh) * | 2004-11-25 | 2007-10-24 | 重庆医药工业研究院有限责任公司 | 制备N-(吡咯并[2,3-d]嘧啶-5-基)酰基谷氨酸衍生物的方法及中间体 |
| JP5475234B2 (ja) | 2005-01-21 | 2014-04-16 | アステックス・セラピューティクス・リミテッド | 医薬化合物 |
| EP2305681A1 (de) | 2006-08-14 | 2011-04-06 | Sicor, Inc. | Kristalline Form der Pemetrexed Disäure und Verfahren zur Herstellung derselben |
| WO2008021411A2 (en) | 2006-08-14 | 2008-02-21 | Sicor Inc. | Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid |
| EP1957497B1 (de) | 2006-08-14 | 2015-09-30 | Sicor, Inc. | Verfahren zur herstellung von zwischenprodukten aus pemetrexed |
| EP1934226A2 (de) | 2006-08-14 | 2008-06-25 | Sicor, Inc. | Pemetrexed-diacid von hoher reinheit und verfahren zu dessen herstellung |
| WO2008044045A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
| EP2073803B1 (de) | 2006-10-12 | 2018-09-19 | Astex Therapeutics Limited | Pharmazeutische kombinationen |
| CN101417998B (zh) | 2007-10-24 | 2012-10-24 | 重庆医药工业研究院有限责任公司 | 一种培美曲塞盐的纯化方法 |
| DK2985025T3 (en) * | 2008-06-06 | 2018-03-19 | Boehringer Ingelheim Int | PHARMACEUTICAL COMPOSITION |
| AU2015210337B2 (en) * | 2008-06-06 | 2017-02-02 | Boehringer Ingelheim International Gmbh | Pharmaceutical combination |
| CN101684121B (zh) * | 2008-09-22 | 2013-04-03 | 重庆医药工业研究院有限责任公司 | 培美曲塞二酸的新晶型及其制备方法 |
| US9174991B2 (en) | 2009-11-24 | 2015-11-03 | Azad Pharmaceutical Ingredients Ag | Crystalline form of pemetrexed disodium |
| DK2854768T3 (en) | 2012-05-30 | 2017-06-12 | Fresenius Kabi Oncology Ltd | PHARMACEUTICAL COMPOSITIONS OF PEMETREXED |
| ITRM20120398A1 (it) | 2012-08-08 | 2014-02-09 | Berlin Chemie Ag | Procedimento di sintesi pemetrexed e suo sale di lisina. |
| US20160051679A1 (en) | 2013-04-12 | 2016-02-25 | Actavis Group Ptc Ehf. | Pemetrexed Formulation |
| WO2014185797A1 (en) | 2013-05-17 | 2014-11-20 | Instytut Farmaceutyczny | Process for the preparation of high purity amorphous pemetrexed disodium and crystalline forms of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3- d] pyrimidin-5-yl)ethyl] benzoyl]-l-glutamic acid |
| EP3008064B1 (de) | 2013-06-14 | 2017-11-22 | Synthon B.V. | Stabile argininsalze von pemetrexed und zusammensetzungen davon |
| US9688682B2 (en) | 2013-07-16 | 2017-06-27 | Dr. Reddy's Laboratories Limited | Crystalline forms of pemetrexed tromethamine salts |
| NZ630292A (en) | 2013-11-25 | 2015-02-27 | Shilpa Medicare Ltd | Process for crystalline pemetrexed dipotassium salt |
| US20180235969A1 (en) | 2014-10-16 | 2018-08-23 | Synthon B.V. | Liquid pharmaceutical composition comprising pemetrexed |
| CN104672241B (zh) * | 2015-01-29 | 2018-04-24 | 王磊 | 吡咯并[2,3-d]嘧啶类化合物及其用途 |
| FR3037956B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN109195593A (zh) | 2016-03-15 | 2019-01-11 | 奥莱松基因组股份有限公司 | 用于治疗实体瘤的lsd1抑制剂的组合 |
| US10793573B2 (en) * | 2017-08-31 | 2020-10-06 | Duquesne University Of The Holy Spirit | First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents |
| CN110305135B (zh) * | 2018-03-20 | 2022-02-22 | 鲁南制药集团股份有限公司 | 一种培美曲塞二钠中间体及其制备方法 |
| CN110305136A (zh) * | 2018-03-20 | 2019-10-08 | 鲁南制药集团股份有限公司 | 一种培美曲塞二钠中间体及其制备方法 |
| CN110305134B (zh) * | 2018-03-20 | 2022-02-22 | 鲁南制药集团股份有限公司 | 一种培美曲塞二钠中间体及其制备方法 |
| CN110305137A (zh) * | 2018-03-20 | 2019-10-08 | 鲁南制药集团股份有限公司 | 一种培美曲塞二钠中间体及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4818819A (en) * | 1986-10-20 | 1989-04-04 | The Trustees Of Princeton University | Process for the preparation of fused pyridine compounds |
| NO169490C (no) * | 1988-03-24 | 1992-07-01 | Takeda Chemical Industries Ltd | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater |
| DK172753B1 (da) * | 1988-05-25 | 1999-06-28 | Lilly Co Eli | N-(5,6,7,8-tetrahydropyrido[2,3--d]pyrimidin-6-yl-alkanoyl)-glutaminsyrederivater, deres anvendelse, farmaceutiske præparat |
| US4883799A (en) * | 1988-06-29 | 1989-11-28 | The Trustees Of Princeton University | N-(4-(1-hydroxy-3-(5,6,7,8-tetrahydropyrido(2,3,-d)-pyrimidin-6-yl)prop-2-yl)benzoyl)glutamic acid derivatives |
-
1990
- 1990-12-04 IL IL9653190A patent/IL96531A/en active Protection Beyond IP Right Term
- 1990-12-05 AU AU67791/90A patent/AU640182B2/en not_active Expired
- 1990-12-07 NZ NZ236385A patent/NZ236385A/en unknown
- 1990-12-10 CA CA002031890A patent/CA2031890C/en not_active Expired - Lifetime
- 1990-12-10 DE DE69025723T patent/DE69025723T2/de not_active Expired - Lifetime
- 1990-12-10 IE IE444590A patent/IE904445A1/en not_active IP Right Cessation
- 1990-12-10 SG SG1996007025A patent/SG48098A1/en unknown
- 1990-12-10 ES ES90123671T patent/ES2084639T4/es not_active Expired - Lifetime
- 1990-12-10 DE DE200512000012 patent/DE122005000012I2/de active Active
- 1990-12-10 HU HU147/90A patent/HU218483B/hu unknown
- 1990-12-10 EP EP90123671A patent/EP0432677B1/de not_active Expired - Lifetime
- 1990-12-10 AR AR90318580A patent/AR245129A1/es active
- 1990-12-10 DK DK90123671.1T patent/DK0432677T3/da active
- 1990-12-10 AT AT90123671T patent/ATE135007T1/de active
- 1990-12-10 PT PT96140A patent/PT96140B/pt not_active IP Right Cessation
- 1990-12-11 JP JP2409992A patent/JP3016876B2/ja not_active Expired - Lifetime
- 1990-12-11 CN CN90110125A patent/CN1030608C/zh not_active Ceased
-
1991
- 1991-02-07 RU SU4894454/04A patent/RU2057131C9/ru active Protection Beyond IP Right Term
-
1996
- 1996-04-29 GR GR960401164T patent/GR3019784T3/el unknown
-
1998
- 1998-09-11 CY CY9802076A patent/CY2076B1/xx unknown
-
2005
- 2005-03-14 LU LU91147C patent/LU91147I2/fr unknown
- 2005-03-16 NL NL300181C patent/NL300181I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE122005000012I1 (de) | N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutamins{urederivate. | |
| FI905983L (fi) | Aminosyraderivat. | |
| DE68915207D1 (de) | Aminosäure-Derivate. | |
| NO901399D0 (no) | Aminosyrederivater. | |
| FI891006A7 (fi) | Aminosyraderivat. | |
| DE59008394D1 (de) | Aminosäureamid-Derivate. | |
| NO903832D0 (no) | Aminosyrederivater. | |
| NO901033L (no) | Aminosyrederivater. | |
| FI884598A7 (fi) | Aminosyraderivat. | |
| DE3787657D1 (de) | Aminosäure-Derivate. | |
| FI892362L (fi) | Buten- eller propensyraderivat. | |
| NO901533L (no) | Aminosyrederivater. | |
| FI900024A7 (fi) | Pyrrolylfenyl-substituerade hydroxamsyraderivat. | |
| FI913179A7 (fi) | Aminosyraderivat. | |
| FI906104L (fi) | Naftylsulfonylalkansyraderivat. | |
| FI891761L (fi) | Aminosyraderivat. | |
| FI883441A7 (fi) | Hydrokanelsyraderivat. | |
| NO892728L (no) | Aminoalkyl-aminokarbonyl-aminodiolaminosyre derivater somanti-hypertensive midler. | |
| DE69018816D1 (de) | Aminosäurederivate. | |
| DE69019217D1 (de) | Perylenquinon (UCN-1028D)-Derivate. | |
| DE59002430D1 (de) | Cyclopropanoylaminosäureamid-Derivate. | |
| NO901519D0 (no) | Aminosyrederivater. | |
| DE3854064D1 (de) | Hydrochinonylphenyl-Buttersäureamid-Derivate. | |
| ATE105549T1 (de) | Aminosaeure-derivate. | |
| ATE95518T1 (de) | Aminosaeure-derivate. |